132 related articles for article (PubMed ID: 34275596)
1. Acute Urinary Retention After Kidney Transplant: Effect on Graft Function, Predictive Factors, and Treatment.
de Oliveira Marinho AC; Tavares-da-Silva E; Bastos CA; Roseiro A; Parada B; Retroz E; Marconi L; Moreira P; Nunes P; Simões P; Santos L; Romãozinho C; Figueiredo A
Transplant Proc; 2021; 53(6):1933-1938. PubMed ID: 34275596
[TBL] [Abstract][Full Text] [Related]
2. Incidence, predictors, and associated outcomes of prostatism after kidney transplantation.
Hurst FP; Neff RT; Falta EM; Jindal RM; Lentine KL; Swanson JS; Agodoa LY; Abbott KC
Clin J Am Soc Nephrol; 2009 Feb; 4(2):329-36. PubMed ID: 19176793
[TBL] [Abstract][Full Text] [Related]
3. Benign prostatic hyperplasia (BPH) requiring transurethral resection in freshly transplanted renal allograft recipients.
Koziolek MJ; Wolfram M; Müller GA; Scheel AK; Strutz F; Scheuermann EH; Kramer W
Clin Nephrol; 2004 Jul; 62(1):8-13. PubMed ID: 15267007
[TBL] [Abstract][Full Text] [Related]
4. [Transurethral plasma resection of the prostate for acute urinary retention in patients with advanced prostate cancer].
Pang K; Liang Q; Chen B; Shi ZD; Dong Y; Han CH
Zhonghua Nan Ke Xue; 2023 Jan; 29(1):25-30. PubMed ID: 37846828
[TBL] [Abstract][Full Text] [Related]
5. The effect of acute urinary retention on the results of transurethral resection of the prostate.
Baran C
Urologia; 2023 Nov; 90(4):642-646. PubMed ID: 37491943
[TBL] [Abstract][Full Text] [Related]
6. Characteristics of recurrent acute urinary retention in BPH patients in the United States: Retrospective analysis of US-based insurance claims database.
Lee S; Yoo KH; Kim TS; Cho HJ; Kim W; Oh JK; Li S; Kim SY; Wei W; Huang J; van Uem S; Del Giudice F; Lindars DP; Sathe AR; Chung BI
Prostate; 2023 May; 83(7):722-728. PubMed ID: 36891865
[TBL] [Abstract][Full Text] [Related]
7. Urodynamic impact of acute urinary retention in patients with benign prostatic hyperplasia: a 2-year follow-up after transurethral resection of the prostate.
Wagenlehner FM; Bescherer K; Wagenlehner C; Zellner M; Weidner W; Naber KG
Urol Int; 2011; 86(1):73-9. PubMed ID: 20689259
[TBL] [Abstract][Full Text] [Related]
8. The effect of immediate surgical bipolar plasmakinetic transurethral resection of the prostate on prostatic hyperplasia with acute urinary retention.
He LY; Zhang YC; He JL; Li LX; Wang Y; Tang J; Tan J; Zhong K; Tang YX; Long Z
Asian J Androl; 2016; 18(1):134-9. PubMed ID: 26178398
[TBL] [Abstract][Full Text] [Related]
9. Acute urinary retention increases the risk of complications after transurethral resection of the prostate: a population-based study.
Chen JS; Chang CH; Yang WH; Kao YH
BJU Int; 2012 Dec; 110(11 Pt C):E896-901. PubMed ID: 23035623
[TBL] [Abstract][Full Text] [Related]
10. Serum prostate-specific antigen concentration is a powerful predictor of acute urinary retention and need for surgery in men with clinical benign prostatic hyperplasia. PLESS Study Group.
Roehrborn CG; McConnell JD; Lieber M; Kaplan S; Geller J; Malek GH; Castellanos R; Coffield S; Saltzman B; Resnick M; Cook TJ; Waldstreicher J
Urology; 1999 Mar; 53(3):473-80. PubMed ID: 10096369
[TBL] [Abstract][Full Text] [Related]
11. Symptom deterioration during treatment and history of AUR are the strongest predictors for AUR and BPH-related surgery in men with LUTS treated with alfuzosin 10 mg once daily.
Emberton M; Elhilali M; Matzkin H; Harving N; van Moorselaar J; Hartung R; Alcaraz A; Vallancien G;
Urology; 2005 Aug; 66(2):316-22. PubMed ID: 16098361
[TBL] [Abstract][Full Text] [Related]
12. Holmium laser prostatic resection for patients presenting with acute urinary retention.
Anderson CB; Helfand BT; McVary KT
BJU Int; 2008 Dec; 102(11):1623-8. PubMed ID: 18710443
[TBL] [Abstract][Full Text] [Related]
13. Is intravesical prostatic protrusion a risk factor for hydronephrosis and renal insufficiency in benign prostate hyperplasia patients?
Lu CH; Wu HHH; Lin TP; Huang YH; Chung HJ; Kuo JY; Huang WJ; Lu SH; Chang YH; Lin ATL
J Chin Med Assoc; 2019 May; 82(5):381-384. PubMed ID: 30893258
[TBL] [Abstract][Full Text] [Related]
14. Clinical progression, acute urinary retention, prostate-related surgeries, and costs in patients with benign prostatic hyperplasia taking early versus delayed combination 5α-reductase inhibitor therapy and α-blocker therapy: a retrospective analysis.
Morlock R; Goodwin B; Gomez Rey G; Eaddy M
Clin Ther; 2013 May; 35(5):624-33. PubMed ID: 23583026
[TBL] [Abstract][Full Text] [Related]
15. The role of bladder diverticula in the prevalence of acute urinary retention in patients with BPH who are candidates to surgery.
Iscaife A; Dos Anjos G; Barbosa C; Nahas WC; Srougi M; Antunes AA
Int Braz J Urol; 2018; 44(4):765-770. PubMed ID: 29617085
[TBL] [Abstract][Full Text] [Related]
16. Rates of prostate surgery and acute urinary retention for benign prostatic hyperplasia in men treated with dutasteride or finasteride.
Kuiper JG; Bezemer ID; Driessen MT; Vasylyev A; Roehrborn CG; Penning-van Beest FJ; Herings RM
BMC Urol; 2016 Aug; 16(1):53. PubMed ID: 27580700
[TBL] [Abstract][Full Text] [Related]
17. A prospective randomized trial comparing transurethral resection of the prostate and laser therapy in men with chronic urinary retention: The CLasP study.
Gujral S; Abrams P; Donovan JL; Neal DE; Brookes ST; Chacko KN; Wright MJ; Timoney AG; Peters TJ
J Urol; 2000 Jul; 164(1):59-64. PubMed ID: 10840425
[TBL] [Abstract][Full Text] [Related]
18. Urinary retention in patients with BPH treated with finasteride or placebo over 4 years. Characterization of patients and ultimate outcomes. The PLESS Study Group.
Roehrborn CG; Bruskewitz R; Nickel GC; Glickman S; Cox C; Anderson R; Kandzari S; Herlihy R; Kornitzer G; Brown BT; Holtgrewe HL; Taylor A; Wang D; Waldstreicher J
Eur Urol; 2000 May; 37(5):528-36. PubMed ID: 10765090
[TBL] [Abstract][Full Text] [Related]
19. A demographic profile of patients undergoing transurethral resection of the prostate for benign prostate hyperplasia and presenting in acute urinary retention.
Loh SY; Chin CM
BJU Int; 2002 Apr; 89(6):531-3. PubMed ID: 11942958
[TBL] [Abstract][Full Text] [Related]
20. Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4-year results from the randomized, double-blind Combination of Avodart and Tamsulosin (CombAT) trial.
Roehrborn CG; Barkin J; Siami P; Tubaro A; Wilson TH; Morrill BB; Gagnier RP
BJU Int; 2011 Mar; 107(6):946-54. PubMed ID: 21332630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
